Back to search

Article

Anti-SLC7A11 monoclonal antibody Inhibits Tumor Progression through a Janus-faced Effect on CD4 + and CD8 + T Cells in Colorectal Cancer

2026-05-08

Abstract excerpt

<title>Abstract</title> <p>Background SLC7A11 is aberrantly overexpressed in many solid tumors, including colorectal cancer (CRC), but its complex 12-transmembrane structure has hindered effective antibody targeting. Methods We generated a human SLC7A11-specific murine monoclonal antibody (SLC7A11-Ab) using cell-based immunization and hybridoma technology. Subcutaneous and orthotopic CRC mouse models were estab...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cea1e0b6-b122-5985-9bab-8df977349385
DOI
10.21203/rs.3.rs-8946667/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Anti-SLC7A11 monoclonal antibody Inhibits Tumor Progression through a Janus-faced Effect on CD4 + and CD8 + T Cells in Colorectal CancerDOI 10.21203/rs.3.rs-8946667/v1
Select a neighboring publication to make it the new centre.